Avantor, Inc.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US05352A1007
USD
11.15
-0.14 (-1.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Avantor, Inc. stock-summary
stock-summary
Avantor, Inc.
Specialty Chemicals
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Company Coordinates stock-summary
Company Details
Building One, 100 W Matsonford Rd Ste 200 RADNOR PA : 19087
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 125 Schemes (58.97%)

Foreign Institutions

Held by 290 Foreign Institutions (28.13%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Rajiv Gupta
Chairman of the Board
Mr. Michael Stubblefield
President, Chief Executive Officer, Director
Mr. Matthew Holt
Director
Mr. Andre Moura
Director
Ms. Jo Natauri
Director
Mr. Juan Andres
Independent Director
Mr. Jonathan Peacock
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,683 Million
(Quarterly Results - Jun 2025)
Net Profit:
65 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 8,951 Million (Small Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.60

stock-summary
Return on Equity

12.05%

stock-summary
Price to Book

1.42